Dupilumab for COPD with Elevated Eosinophil Counts. Reply

N Engl J Med. 2024 Sep 26;391(12):1164. doi: 10.1056/NEJMc2409963.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibodies, Monoclonal / therapeutic use
  • Antibodies, Monoclonal, Humanized* / therapeutic use
  • Eosinophilia / drug therapy
  • Eosinophils* / drug effects
  • Humans
  • Leukocyte Count
  • Pulmonary Disease, Chronic Obstructive* / drug therapy

Substances

  • Antibodies, Monoclonal, Humanized
  • dupilumab
  • Antibodies, Monoclonal